Found: 57
Select item for more details and to access through your institution.
Safety and efficacy of beclomethasone dipropionate delivered by breath-actuated or metered-dose inhaler for persistent asthma.
- Published in:
- Allergy & Asthma Proceedings, 2016, v. 37, n. 5, p. 359, doi. 10.2500/aap.2016.37.3983
- By:
- Publication type:
- Article
Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroids.
- Published in:
- Allergy & Asthma Proceedings, 2009, v. 30, n. 3, p. 304, doi. 10.2500/aap.2009.30.3242
- By:
- Publication type:
- Article
Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Clinical Effect of Danirixin in Adults With Acute, Uncomplicated Influenza.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 4, p. N.PAG, doi. 10.1093/ofid/ofz072
- By:
- Publication type:
- Article
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 3105, doi. 10.2147/COPD.S331636
- By:
- Publication type:
- Article
Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 1939, doi. 10.2147/COPD.S291751
- By:
- Publication type:
- Article
Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 1215, doi. 10.2147/COPD.S295835
- By:
- Publication type:
- Article
A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 1137, doi. 10.2147/COPD.S307160
- By:
- Publication type:
- Article
Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies.
- Published in:
- International Journal of COPD, 2020, v. 15, p. 2309, doi. 10.2147/COPD.S267249
- By:
- Publication type:
- Article
Observational Real-World Study to Assess Clinical Characteristics and Device Satisfaction in Patients with COPD Treated with Glycopyrrolate/eFlow<sup>®</sup> CS.
- Published in:
- International Journal of COPD, 2020, v. 16, p. 1713, doi. 10.2147/COPD.S248760
- By:
- Publication type:
- Article
Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy.
- Published in:
- International Journal of COPD, 2020, v. 16, p. 1225, doi. 10.2147/COPD.S244942
- By:
- Publication type:
- Article
An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD.
- Published in:
- International Journal of COPD, 2019, v. 14, p. 2835, doi. 10.2147/COPD.S217710
- By:
- Publication type:
- Article
Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD.
- Published in:
- International Journal of COPD, 2019, v. 14, p. 615, doi. 10.2147/COPD.S190603
- By:
- Publication type:
- Article
AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD.
- Published in:
- International Journal of COPD, 2019, v. 14, p. 667, doi. 10.2147/COPD.S189138
- By:
- Publication type:
- Article
Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT.
- Published in:
- International Journal of COPD, 2019, v. 14, p. 479, doi. 10.2147/COPD.S185502
- By:
- Publication type:
- Article
Effect of background long-acting beta<sub>2</sub>-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD.
- Published in:
- International Journal of COPD, 2018, v. 13, p. 2917, doi. 10.2147/COPD.S172408
- By:
- Publication type:
- Article
Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD.
- Published in:
- International Journal of COPD, 2018, v. 13, p. 1965, doi. 10.2147/COPD.S166455
- By:
- Publication type:
- Article
Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD.
- Published in:
- International Journal of COPD, 2018, v. 13, p. 1483, doi. 10.2147/COPD.S164281
- By:
- Publication type:
- Article
Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study.
- Published in:
- International Journal of COPD, 2017, v. 12, p. 745, doi. 10.2147/COPD.S119032
- By:
- Publication type:
- Article
Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data.
- Published in:
- International Journal of COPD, 2015, p. 1599, doi. 10.2147/COPD.S81266
- By:
- Publication type:
- Article
Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data.
- Published in:
- International Journal of COPD, 2015, v. 10, p. 1599, doi. 10.2147/COPD.S81266
- By:
- Publication type:
- Article
Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial.
- Published in:
- International Journal of COPD, 2012, v. 7, p. 43, doi. 10.2147/COPD.S27319
- By:
- Publication type:
- Article
Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials.
- Published in:
- International Journal of COPD, 2012, v. 7, p. 73, doi. 10.2147/COPD.S29444
- By:
- Publication type:
- Article
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD.
- Published in:
- International Journal of COPD, 2012, v. 7, p. 57, doi. 10.2147/COPD.S27320
- By:
- Publication type:
- Article
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study.
- Published in:
- Respiratory Research, 2014, v. 15, n. 10, p. 1, doi. 10.1186/s12931-014-0123-0
- By:
- Publication type:
- Article
Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.
- Published in:
- Lung, 2017, v. 195, n. 6, p. 739, doi. 10.1007/s00408-017-0055-9
- By:
- Publication type:
- Article
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum].
- Published in:
- Journal of Asthma & Allergy, 2020, v. 13, p. 135, doi. 10.2147/JAA.S251079
- By:
- Publication type:
- Article
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA).
- Published in:
- Journal of Asthma & Allergy, 2020, v. 13, p. 115, doi. 10.2147/JAA.S240044
- By:
- Publication type:
- Article
Real-world health care utilization in asthma patients using albuterol sulfate inhalation aerosol (ProAir® HFA) with and without integrated dose counters.
- Published in:
- Journal of Asthma & Allergy, 2017, v. 10, p. 171, doi. 10.2147/JAA.S130836
- By:
- Publication type:
- Article
A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and Safety of Nebulized Formoterol as Add-on Therapy in COPD Patients Receiving Maintenance Tiotropium Bromide Results from a 6-Week, Randomized, Placebo-Controlled, Clinical Trial.
- Published in:
- Drugs, 2009, v. 69, n. 9, p. 1205, doi. 10.2165/00003495-200969090-00005
- By:
- Publication type:
- Article
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, p. 1, doi. 10.1177/1753466620968500
- By:
- Publication type:
- Article
Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620926949
- By:
- Publication type:
- Article
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, p. 1, doi. 10.1177/1753466620968500
- By:
- Publication type:
- Article
Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, p. 1, doi. 10.1177/1753466620926949
- By:
- Publication type:
- Article
Indacaterol 75 µg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2013, v. 7, n. 1, p. 25, doi. 10.1177/1753465812470018
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 1, p. 55, doi. 10.1007/s40261-015-0346-y
- By:
- Publication type:
- Article
Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2013, v. 188, n. 11, p. 1294, doi. 10.1164/rccm.201212-2318OC
- By:
- Publication type:
- Article
Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 6, p. 579, doi. 10.1007/s40261-021-01040-7
- By:
- Publication type:
- Article
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
- Published in:
- Chronic Respiratory Disease, 2023, v. 20, p. 1, doi. 10.1177/14799731231202257
- By:
- Publication type:
- Article
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
- Published in:
- Chronic Respiratory Disease, 2023, v. 20, p. 1, doi. 10.1177/14799731231202257
- By:
- Publication type:
- Article
A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD).
- Published in:
- 2019
- By:
- Publication type:
- journal article